ArticleScientific reports2026

Potent LeuBAT inhibitors designed in silico as next-generation duloxetine analogs for enhanced major depressive disorder treatment.

Mehdi Yoosefian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.